202 related articles for article (PubMed ID: 9298056)
1. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
[TBL] [Abstract][Full Text] [Related]
2. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
4. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
[TBL] [Abstract][Full Text] [Related]
5. Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
Nguyen DT; Houillier C; Choquet S; Cassoux N; Soussain C; Le Cossec C; Legarf-Tavernier M; Costopoulos M; LeHoang P; Bodaghi B; Omuro A; Hoang-Xuan K; Touitou V
Ophthalmology; 2016 Sep; 123(9):2047-50. PubMed ID: 27137876
[No Abstract] [Full Text] [Related]
6. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
[TBL] [Abstract][Full Text] [Related]
7. [Intravitreal chemotherapy for intraocular lymphoma].
Helbig H; Cerny T; de Smet MD
Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
[TBL] [Abstract][Full Text] [Related]
8. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal methotrexate injections for intraocular involvement in primary central nervous system lymphoma.
Tourville E; Tardif Y
Can J Ophthalmol; 2003 Dec; 38(7):598-601. PubMed ID: 14740803
[No Abstract] [Full Text] [Related]
10. Intraocular chemotherapy for vitreoretinal lymphoma: A review.
Kvopka M; Lake SR; Smith JR
Clin Exp Ophthalmol; 2020 Mar; 48(2):240-248. PubMed ID: 31680408
[TBL] [Abstract][Full Text] [Related]
11. Relevance of intraocular involvement in the management of primary central nervous system lymphomas.
Ferreri AJ; Blay JY; Reni M; Pasini F; Gubkin A; Tirelli U; Calderoni A; Zucca E; Cortelazzo S; Chassagne C; Tinguely M; Borisch B; Berger F; Ponzoni M; Cavalli F;
Ann Oncol; 2002 Apr; 13(4):531-8. PubMed ID: 12056702
[TBL] [Abstract][Full Text] [Related]
12. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
13. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
Zhou N; Xu X; Liu Y; Wang Y; Wei W
Eye (Lond); 2022 Jul; 36(7):1448-1455. PubMed ID: 34211136
[TBL] [Abstract][Full Text] [Related]
14. Analysis of radiotherapy in 1054 patients with primary central nervous system lymphoma treated from 1985 to 2009.
Shibamoto Y; Sumi M; Takemoto M; Tsuchida E; Onodera S; Matsushita H; Sugie C; Tamaki Y; Onishi H
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):653-60. PubMed ID: 25034088
[TBL] [Abstract][Full Text] [Related]
15. Two cases of primary intraocular lymphoma: fine needle aspiration diagnosis and intravitreal methotrexate treatment.
Zhao T; Li Y; Tang L; Wei X; Zhu X
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):142-144. PubMed ID: 21336740
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
[TBL] [Abstract][Full Text] [Related]
17. A case of primary intraocular lymphoma treated by intravitreal methotrexate.
Kim E; Kim C; Lee J; Cho Y
Korean J Ophthalmol; 2009 Sep; 23(3):210-4. PubMed ID: 19794951
[TBL] [Abstract][Full Text] [Related]
18. Treatment of primary intraocular lymphoma with intravitreal methotrexate.
Sou R; Ohguro N; Maeda T; Saishin Y; Tano Y
Jpn J Ophthalmol; 2008; 52(3):167-174. PubMed ID: 18661266
[TBL] [Abstract][Full Text] [Related]
19. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma.
O'Brien P; Roos D; Pratt G; Liew K; Barton M; Poulsen M; Olver I; Trotter G
J Clin Oncol; 2000 Feb; 18(3):519-26. PubMed ID: 10653867
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal injections of methotrexate in treatment of primary central nervous system lymphoma with intraocular involvement.
Huang YC; Jou JR
Kaohsiung J Med Sci; 2016 Dec; 32(12):638-639. PubMed ID: 27914618
[No Abstract] [Full Text] [Related]
[Next] [New Search]